Dizziness or hypotension · dialysis patients with depression
1 finding from 1 review
Nausea · dialysis patients with depression
1 finding from 1 review
Sexual dysfunction ‐ not reported · dialysis patients with depression
1 finding from 1 review
All‐cause mortality · dialysis patients with depression
1 finding from 1 review
Depression at endpoint · patients with depression and dementia
1 finding from 1 review
Number of responders · patients with depression and dementia
Antidepressant treatment showed no clear difference in number of responders (ITT) at 6 to 12 weeks compared with placebo (low certainty).
1 finding from 1 review
Remission · patients with depression and dementia
Antidepressant treatment probably leads to higher number of patients with remission (ITT) at 6 to 12 weeks compared with placebo (moderate certainty).
1 finding from 1 review
Cognitive function · patients with depression and dementia
1 finding from 1 review
Activities of daily living · patients with depression and dementia
1 finding from 1 review
Dropout · patients with depression and dementia
Antidepressant treatment probably leads to higher number of dropouts at 6 to 13 weeks compared with placebo (moderate certainty).
1 finding from 1 review
Risk for at least one adverse event per patient · patients with depression and dementia
Antidepressant treatment probably leads to higher number of patients experiencing at least one adverse event compared with placebo (moderate certainty).
1 finding from 1 review
Pain < 1 week VAS scale 0 to 100 mm · patients with pain management in rheumatoid arthritis
1 finding from 1 review
Pain 1 to 6 weeks Any pain measurement scale · patients with pain management in rheumatoid arthritis
1 finding from 1 review
Pain > 6 weeks Any pain measurement scale · patients with pain management in rheumatoid arthritis
1 finding from 1 review
Functional Status Health Assessment Questionnaire (HAQ) scale 0 to 3 · patients with pain management in rheumatoid arthritis
1 finding from 1 review
Withdrawals due to adverse events · patients with pain management in rheumatoid arthritis
It is very uncertain whether tricyclic antidepressant changes number of Withdrawals due to Adverse Events patient interview compared with control (very low certainty).
1 finding from 1 review
Total number of adverse events patient interview · patients with pain management in rheumatoid arthritis
It is very uncertain whether tricyclic antidepressant changes total number of adverse events patient interview compared with control (very low certainty).
1 finding from 1 review
Relapse · participants with long‐term antidepressants for depressive or anxiety disorders
1 finding from 1 review
Withdrawal symptoms · participants with long‐term antidepressants for depressive or anxiety disorders
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse events · participants with long‐term antidepressants for depressive or anxiety disorders
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found